Harvard Apparatus Regenerative Technology
Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company that develops regenerative-medicine treatments for disorders of the gastrointestinal system and airways. Its core focus is the proprietary Cellspan™ technology platform, which uses a patient's own stem cells to regenerate and restore function to damaged organs. The company also generates secondary revenue from selling consumer health products in Asia.
Products & Team
Cellspan™ Esophageal Implant
The Cellspan™ Esophageal Implant is a bioengineered implant designed to treat conditions of the esophagus resulting from cancer, trauma, birth defects such as esophageal atresia, or damage from chemoradiation. It is a 'living tube' created by seeding a patient's own stem cells onto a proprietary, biocompatible scaffold that mimics the dimensions of the damaged organ, designed to trigger the body's natural healing processes to regenerate the tissue.
It addresses the critical need for a functional organ replacement for patients suffering from end-stage esophageal disease, potentially avoiding the complications associated with traditional reconstructive surgery or synthetic implants.
Patients face life-altering conditions caused by the removal or severe damage of their esophagus or airways, for which current treatment options are limited, highly invasive, or carry significant risks and complications.